Nuremberg Code Nuremberg Code Public becomes more aware of potential research ethics problems in U.S. funded/conducted studies - Jewish Chronic Disease Hospital
- Henry Beecher 1966 NEJM article
- Tuskegee study
Tuskegee Ad Hoc panel convened 1972
Beneficence: Beneficence: - duty to protect the welfare of participants
Respect for persons - duty to respect autonomous persons, their choices, and their information
- Out of respect, duty to protect those less than fully autonomous
Justice - Duty to distribute benefits and burdens fairly
Risks/benefits: to individuals and communities - Physical
- Psychological
- Social
Considerations when assessing risk: - Nature of risk
- Likelihood of risk
- Severity/magnitude of harm
- Permanence/reversibility of harm
Valid design? Valid findings? If not, no benefit - Valid design? Valid findings? If not, no benefit
- Sufficient sample size?
- Is randomization appropriate?
- Are placebos appropriate?
- Surrogate markers vs. clinical endpoints?
- Often can change design to reduce risk
Requires we go through informed consent process Requires we go through informed consent process Requires we respect privacy and maintain confidentiality
Disclosure Disclosure Understanding Voluntariness Capacity (competence)
Average reading level >8th grade (numerous studies) Average reading level >8th grade (numerous studies) 65 approved forms: avg. 15th grade (Hammerschmidt and Keane 1992) - Ann Landers columns avg 7.7 grade
- Reader’s Digest avg 9.95 grade readability
- IRB review never improved by >1 grade level
IRBs’ own boilerplate often >8th grade - (Paasche-Orlow et al 2003)
Appelbaum: “therapeutic misconception” Appelbaum: “therapeutic misconception” - 69% didn’t know how random assignment had been made
- 32% thought they were in group best for therapeutic needs
- 44% did not know some patients who wanted tx would not get it
- 39% did not understand MD would not know which tx they received
Riecken and Ravich - 28% didn’t know they were in study, despite having just signed consent form
Shortening form (Epstein 1969) Shortening form (Epstein 1969) - Overall comprehension: 67% vs. 35%
Lowering readability level (Young 1990) - Purpose: 77% vs. 44%; Side effects: 72% vs. 58%
More sections, headings, lay language (Bjorn 1999) - Randomization: 26% vs. 42%
Corrected feedback or verbalization - Quiz and correct wrong answers (Taub 1984)
- Verbalization of surgical risks (Wadey 1997)
Fair selection of individuals Fair selection of individuals Opposite is exploitation
Overall research portfolio Overall research portfolio - What diseases do we study?
- Who gets them? How many people? Which groups?
- Fair distribution of who benefits from overall research?
Which population do we pick for individual studies? - Is study particularly relevant to THEM?
- If not, is there a fair distribution/broad inclusion?
What happens after study is over? - Access to successful intervention?
- Does fairness require this?
IRB must review studies for adherence to ethics principles, including: IRB must review studies for adherence to ethics principles, including: - Review risk/benefit; risks minimized
- Review consent elements/procedures and documentation
- Review proper selection of subjects
1991: adopted by 17 US federal agencies as “Common Rule”
Think through ethics issues for your project – minimize harms, choose populations fairly, develop respectful procedures Think through ethics issues for your project – minimize harms, choose populations fairly, develop respectful procedures Submit protocol to IRB, submit annual reviews to IRB, submit changes to IRB, submit adverse or unanticipated events to IRB Maintain records (with IRB, with subjects) Honesty and integrity as an investigator
You must follow regulations You must follow regulations You must be thoughtful about the ethics of your studies If you’re lucky, these will happen at the same time
Dostları ilə paylaş: |